Abstract:Surface immunogenic protein(Sip) is a kind of immune related protein that exists in group B Streptococcus,which expresses in many serotypes of GBS.In this present study,Sip gene was amplified from the genomic DNA of a Streptococcus agalactiae strain isolated from sick pond-cultured tilapia in Guangdong province,China.The Sip gene contained a 1305 bp Open Reading Frame(ORF),which encoded 434 amino acids.The molecular mass of the deduced amino acid sequences was 56 kD.Blast analysis showed that it shared high identities(100%) with Sip sequences of human GBS registered in GenBank,while lower identities( 50%) was found compared with other species of Streptococcus.Prediction of epitopes by DNAStar software showed that the deduced amino acid sequence of this Sip gene could form 29 epitopes indicating strong immunogenicity of the Sip.Prokaryotic expression vector pColdII was used to construct a recombinant expression vector pColdII-Sip.Employing PCR method,the cloned Sip gene was modified with primers carried two specific restriction enzyme digested sites,KpnI and HindⅢ.The amplified product,as well as pColdII,were digested respectively.After purification and ligation,the ligated DNA was transferred into E.coli BL21(DE3) strain.The recombinant expression vector pColdII-Sip was selected and then induced to express by 1 mmol/L IPTG for 24h at 15℃.SDS-PAGE analysis and Western blot showed that a specific band of protein about 57 kD in molecular weight was obtained.SDS-PAGE analysis of the induced samples found that the target protein was detected only in the supernant rather than in precipitate,suggesting that it was solubly expressed.The purification of the protein was up to 98% after purified with nickel chelate affinity chromatography.To analyze the immunogenicity of the recombinant protein,tilapia(Oreochromis niloticus,GIFT strain) was immunized by intraperitoneal injection of the recombinant protein.Three immune dosages,1 μg/g,3 μg/g and 5 μg/g were used.Two weeks after immunity,tilapia was challenged by artificial infection of GBS GDzl strain,which had been previously isolated and confirmed to be tilapia pathogen by our lab.The recorded relative percent survival(RPS) of the vaccinated groups ranged from 70% to 87%.Enzyme-linked immunosorbent assay(ELISA) showed that the recombinant protein could induce strong immune response of the tested fish.The serum titers of the fish immunized with 1 μg/g of Sip protein was 1∶16000,and the serum titers of the fish immunized with 3 μg/g or 5 μg/g of Sip protein reached 1∶128000.The result showed that the recombinant protein possessed strong immunogenicity,and Sip gene could be a candidate gene for genetic engineering vaccine.

Immunogenicity and Function of Surface Immunogenic Protein of Group B Streptococcus

Mucosal Immune Effect of Group B Streptococcal Surface Immunogenic Protein

Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines

Intranasal Immunization with GBS Surface Protein Sip and ScpB Induces Specific Mucosal and Systemic Immune Responses in Mice

The Optimisation of the Expression of Recombinant Surface Immunogenic Protein of Group B Streptococcus in Escherichia coli by Response Surface Methodology Improves Humoral Immunity

Surface protein distribution in Group B Streptococcus isolates from South Africa and identifying vaccine targets through in silico analysis

Surface Structures of Group B Streptococcus Important in Human Immunity

Mucosal Vaccination with Lactococcus lactis-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B Streptococcus in a Murine Model

Surface Immunogenic Protein of Streptococcus Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune Adjuvant

Synthesis and immunological study of tetrasaccharide repeating units of capsular polysaccharide of Group B Streptococcus serotype VIII and their protein conjugates

[Construction of Expression Vector Containing S. Mutans GBR Gene and Confirmation of the Immunogenicity of the Recombinant GBR Protein].

Development and Evaluation of a Multi-Epitope Subunit Vaccine Against Group B Streptococcus Infection

Pooled Protein Immunization for Identification of Cell Surface Antigens in Streptococcus Sanguinis

A CRISPRi Library Screen in Group B Streptococcus Identifies Surface Immunogenic Protein (Sip) as a Mediator of Multiple Host Interactions

Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine

Protein Typing of Major Outer Membrane Lipoproteins from Chinese Pathogenic Leptospira Spp. and Characterization of Their Immunogenicity

Evaluation of the Protective Efficacy of Four Novel Identified Membrane Associated Proteins of Streptococcus Suis Serotype 2.

CLONING, EXPRESSION AND IMMUNOGENICITY ANALYSIS OF SURFACE IMMUNOGENIC PROTEIN (SIP) OF TILAPIA STREPTOCOCCUS AGALACTIAE

Prokaryotic cell expression of the surface antigen 1 gene from GJS strain of Toxoplasma gondii and its antigenicity analysis

Immunogenicity of Multi-Epitope Vaccines Composed of Epitopes from Streptococcus Dysgalactiae GapC

Tandem expression and immune activity of major antigenic domain of ancillary proteins BP and AP2 in pilus island of Streptococcus agalactiae